The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies

The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies

Nonalcoholic fatty liver disease (NAFLD) encompasses a broad spectrum of pathological hepatic conditions ranging from simple steatosis to nonalcoholic steatohepatitis (NASH), which may predispose to liver cirrhosis and hepatocellular carcinoma (HCC). Due to the epidemic obesity, NAFLD is representin...

Full description

Bibliographic Details
Main Authors:	Marica Meroni, Miriam Longo, Paola Dongiovanni
Format:	Article
Language:	English
Published:	MDPI AG 2019-11-01
Series:	Nutrients
Subjects:	nonalcoholic fatty liver disease gut microbiota gut–liver axis leaky gut intestinal permeability tight junctions endotoxemia probiotics
Online Access:	https://www.mdpi.com/2072-6643/11/11/2642

Similar Items

Alcohol or Gut Microbiota: Who Is the Guilty?
by: Marica Meroni, et al.
Published: (2019-09-01)

The Role of Leaky Gut in Nonalcoholic Fatty Liver Disease: A Novel Therapeutic Target
by: Takaomi Kessoku, et al.
Published: (2021-07-01)

The Role of Intestinal Bacteria Overgrowth in Obesity-Related Nonalcoholic Fatty Liver Disease
by: Silvia M. Ferolla, et al.
Published: (2014-12-01)

Herbal therapy for ameliorating nonalcoholic fatty liver disease via rebuilding the intestinal microecology
by: Xiao-Fang Yang, et al.
Published: (2021-07-01)

Translational Approaches with Antioxidant Phytochemicals against Alcohol-Mediated Oxidative Stress, Gut Dysbiosis, Intestinal Barrier Dysfunction and Fatty Liver Disease
by: Jacob W. Ballway, et al.
Published: (2021-03-01)

Probiotics in non-alcoholic fatty liver disease: which and when
by: Ludovico Abenavoli, et al.
Published: (2013-05-01)

Enteric Pathogens and Their Toxin-Induced Disruption of the Intestinal Barrier through Alteration of Tight Junctions in Chickens
by: Wageha A. Awad, et al.
Published: (2017-02-01)

Chitosan Oligosaccharide Ameliorates Nonalcoholic Fatty Liver Disease (NAFLD) in Diet-Induced Obese Mice
by: Minyi Qian, et al.
Published: (2019-07-01)

New Insights of OLFM2 and OLFM4 in Gut‐Liver Axis and Their Potential Involvement in Nonalcoholic Fatty Liver Disease
by: Aguilar, C., et al.
Published: (2022)

Effectiveness of Probiotics and Prebiotics Against Acute Liver Injury: A Meta-Analysis
by: Sheng Xu, et al.
Published: (2021-09-01)

Endotoxin Producers Overgrowing in Human Gut Microbiota as the Causative Agents for Nonalcoholic Fatty Liver Disease
by: Na Fei, et al.
Published: (2020-02-01)

Leaky Gut: Effect of Dietary Fiber and Fats on Microbiome and Intestinal Barrier
by: Haruki Usuda, et al.
Published: (2021-07-01)

Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
by: Na Young Lee, et al.
Published: (2021-01-01)

Gut Microbiota and Chemical-Induced Acute Liver Injury
by: Tao Chen, et al.
Published: (2021-05-01)

Effect of Korea red ginseng on nonalcoholic fatty liver disease: an association of gut microbiota with liver function
by: Ji Taek Hong, et al.
Published: (2021-03-01)

Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis
by: Silvia M. Ferolla, et al.
Published: (2016-06-01)

Effects of Vitamin D-Deficient Diet on Intestinal Epithelial Integrity and Zonulin Expression in a C57BL/6 Mouse Model
by: Chun-Yan Yeung, et al.
Published: (2021-08-01)

Niacin and Butyrate: Nutraceuticals Targeting Dysbiosis and Intestinal Permeability in Parkinson’s Disease
by: Tennekoon B. Karunaratne, et al.
Published: (2021-12-01)

Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature
by: Ivana Milosevic, et al.
Published: (2019-01-01)

Alcohol and the Intestine
by: Sheena Patel, et al.
Published: (2015-10-01)

The Molecular and Mechanistic Insights Based on Gut–Liver Axis: Nutritional Target for Non-Alcoholic Fatty Liver Disease (NAFLD) Improvement
by: Yun Ji, et al.
Published: (2020-04-01)

Role of Gut Microbiota in Hepatocarcinogenesis
by: Haripriya Gupta, et al.
Published: (2019-05-01)

Leaky Gut As a Danger Signal for Autoimmune Diseases
by: Qinghui Mu, et al.
Published: (2017-05-01)

Intestinal mycobiota in health and diseases: from a disrupted equilibrium to clinical opportunities
by: Xiaoyan Wu, et al.
Published: (2021-03-01)

Novel Insights Into Pathogenesis and Therapeutic Strategies of Hepatic Encephalopathy, From the Gut Microbiota Perspective
by: Jiachen Liu, et al.
Published: (2021-02-01)

Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis
by: Fuxi Li, et al.
Published: (2021-02-01)

Metagenome of Gut Microbiota of Children With Nonalcoholic Fatty Liver Disease
by: Yuzhen Zhao, et al.
Published: (2019-12-01)

Probiotics, prebiotics and amelioration of diseases
by: Yu-Ling Tsai, et al.
Published: (2019-01-01)

Fecal Microbiota Transplantation in Patients with HBV Infection or Other Chronic Liver Diseases: Update on Current Knowledge and Future Perspectives
by: Mattia Paratore, et al.
Published: (2021-06-01)

Liver Steatosis, Gut-Liver Axis, Microbiome and Environmental Factors. A Never-Ending Bidirectional Cross-Talk
by: Agostino Di Ciaula, et al.
Published: (2020-08-01)

Diet-Regulating Microbiota and Host Immune System in Liver Disease
by: Jung A Eom, et al.
Published: (2021-06-01)

The Roles of the Gut Microbiota and Toll-like Receptors in Obesity and Nonalcoholic Fatty Liver Disease
by: Kouichi Miura, et al.
Published: (2017-06-01)

Gut microbiota in obesity and nonalcoholic fatty liver disease
by: Lina Guo, et al.
Published: (2021-06-01)

Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis
by: Norihisa Nishimura, et al.
Published: (2021-06-01)

Antidepressive Mechanisms of Probiotics and Their Therapeutic Potential
by: Shin Jie Yong, et al.
Published: (2020-01-01)

Ginsenosides Improve Nonalcoholic Fatty Liver Disease via Integrated Regulation of Gut Microbiota, Inflammation and Energy Homeostasis
by: Wenyi Liang, et al.
Published: (2021-02-01)

Heart Failure Disturbs Gut–Blood Barrier and Increases Plasma Trimethylamine, a Toxic Bacterial Metabolite
by: Adrian Drapala, et al.
Published: (2020-08-01)

Dysregulated bile acid receptor-mediated signaling and IL-17A induction are implicated in diet-associated hepatic health and cognitive function
by: Prasant Kumar Jena, et al.
Published: (2020-11-01)

Boom of probiotics: This time non-alcoholic fatty liver disease – A mini review
by: Shayan Mohammadmoradi, et al.
Published: (2014-11-01)

Gastrointestinal Digestion of a Grape Pomace Extract: Impact on Intestinal Barrier Permeability and Interaction with Gut Microbiome
by: Diego Taladrid, et al.
Published: (2021-07-01)